Skip to content

Clinical trials

Completed Endometrial Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Status: Completed Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20192
20201
20211
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University2
Merck Sharp & Dohme LLC2
Akeso1
Karyopharm Therapeutics Inc1
Laekna Limited1
Peking Union Medical College Hospital1
Peking University People's Hospital1
Risen (Suzhou) Pharma Tech Co., Ltd.1
Sichuan Cancer Hospital and Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms11
Uterine Cervical Neoplasms5
Ovarian Neoplasms3
Breast Neoplasms1
Esophageal Neoplasms1
Fallopian Tube Neoplasms1
Genital Diseases1
Neoplasm Metastasis1
Neoplasms1
Neoplasms by Site1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.